Proxies introduce bias in decoding TORC1 activity

Area of Science:

• Molecular Biology
• Cellular Biology
• Biochemistry

Background:

• The mechanistic target of rapamycin complex 1 (mTORC1) kinase is a central regulator of cell growth, metabolism, and homeostasis.
• mTORC1 integrates diverse signals including nutrients, energy status, and growth factors.
• Dysregulation of mTORC1 signaling is implicated in various human diseases, such as cancer, neurodegeneration, and metabolic disorders.

Purpose of the Study:

• To investigate the reliability of commonly used downstream targets for quantifying mTORC1 activity in yeast.
• To determine if different mTORC1 effectors provide consistent readouts of kinase activity under varying conditions.

Main Methods:

• Utilized yeast (Saccharomyces cerevisiae) as a model organism.
• Assessed the phosphorylation status of two key mTORC1 targets: Sch9 and ribosomal protein S6 (Rps6).
• Manipulated cellular conditions through rapamycin treatment and alterations in nitrogen availability.

Main Results:

• Sch9 and Rps6 displayed differential phosphorylation patterns in response to rapamycin treatment.
• Distinct phosphorylation profiles were observed for Sch9 and Rps6 when nitrogen availability was changed.
• These findings indicate that the selection of mTORC1 proxy targets can introduce bias in activity measurements.

Conclusions:

• The choice of downstream effectors significantly impacts the assessment of mTORC1 kinase activity.
• Researchers must carefully consider the specific targets used to quantify mTORC1 signaling to avoid biased interpretations.
• This study highlights the complexity of using proxy markers for kinase activity and emphasizes the need for validation across multiple targets.